Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

We note that the Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) MD of Strategic Accounts & Director, Robert Pallé, recently sold US$52k worth of stock for US$1.30 per share. However we note that the sale only shrunk their holding by 1.5%.

Check out our latest analysis for Blonder Tongue Laboratories

The Last 12 Months Of Insider Transactions At Blonder Tongue Laboratories

Notably, that recent sale by Robert Pallé is the biggest insider sale of Blonder Tongue Laboratories shares that we've seen in the last year. So what is clear is that an insider saw fit to sell at around the current price of US$1.17. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

I will like Blonder Tongue Laboratories better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Blonder Tongue Laboratories insiders own about US$7.5m worth of shares (which is 63% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

What Might The Insider Transactions At Blonder Tongue Laboratories Tell Us?

An insider sold Blonder Tongue Laboratories shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Blonder Tongue Laboratories. Every company has risks, and we've spotted 3 warning signs for Blonder Tongue Laboratories you should know about.

Of course Blonder Tongue Laboratories may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

When trading Blonder Tongue Laboratories or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.